Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 1996
Publications 1996

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Airaksinen MM, Julkunen R. Ruoansulatuskanavan lääkkeet.
2 Aittoniemi J et al. Age-dependent variation in the serum concentration of mannan-binding protein.
3 Collin P et al. Infertility and coeliac disease.
4 Elomaa I et al. Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma.
5 Ferrannini E et al. Insulin action and age.
6 Forslund T. ACE-hemmere of angioodem.
7 Färkkilä M et al. Uutta ICD-10 tautiluokitusta gastroenterologian osalta koskeva tulkinnallinen suositus.
8 Färkkilä M et al. Suositus Helicobacter pylori -infektion diagnostiikasta, hoidosta ja seurannasta.
9 Haffner SM et al. A prospective analysis of the HOMA model.
10 Haffner SM et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: The insulin resistance atherosclerosis study.
11 Haffner SM et al. Leptin concetrations in relation to overall adiposity and regional body fat distribution in Mexican Americans.
12 Haffner SM et al. Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men.
13 Haffner SM et al. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance.
14 Haffner SM et al. Metabolic precursors of hypertension: The San Antonio Heart Study.
15 Haffner SM et al. Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
16 Haffner SM et al. Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes.
17 Haffner SM et al. Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
18 Haffner SM et al. Apolipoprotein E polymorphism and LDL size in a Biethnic population.
19 Haffner SM et al. Leptin concentrations in diabetic and nondiabetic Mexican-Americans.
20 Hansson L et al. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
21 Hartikainen J et al. Sympathetic reinnervation after acute myocardial infarction.
22 Hartikainen JEK et al. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.
23 Hartikainen JEK et al. Predictive power of heart rate variability used as a stratifier of cardiac mortality after myocardial infarction in patients discharged with and without beta-blocker therapy.
24 Heikkinen M et al. General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment and investigations.
25 Heikkinen M et al. Terveyskeskuslääkäri ja dyspepsiapotilas. Katsaus potilaskäynteihin, tutkimuksiin ja hoitoon.
26 Helkala E-L et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study.
27 Hänninen T et al. Prevalence of ageing-associated cognitive decline in an elderly population.
28 Jantunen E et al. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation after allogeneic bone marrow transplantation.
29 Jantunen E, Laakso M. Bisphosphonates in multiple myeloma: current status: future perspectives.
30 Jantunen E, Niskanen L. Bisfosfonaattien kliininen käyttö.
31 Jantunen E, Nousiainen T. Pulsed dexamethasone for refractory idiopathic thrombocytopenic purpura.
32 Jantunen E et al. Antrasykliinihoidon sydänhaitat.
33 Jönsson B et al. Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S).
34 Kaipiainen-Seppänen O et al. Incidence of rheumatoid arthritis in Finland during 1980-1990.
35 Kaipiainen-Seppänen O et al. Shift in the incidence of rheumatoid arthritis towards wlderly patients in Finland during 1975-1990.
36 Kaipiainen-Seppänen O et al. Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies.
37 Kangas T et al. Structure and costs of health care of diabetic patients in Finland.
38 Karhunen LJ et al. Determinants of the cephalic-phase insulin response in obese nondiabetic subjects.
39 Kautzner J et al. Is vagal innervation to the atrioventricular node impaired after radiofrequency ablation of the slow atrioventricular nodal pathway?
40 Kautzner J et al. Arterial baroreflex sensitivity assessed from phase IV of the Valsalva maneuver.
41 Kekäläinen P et al. Femoral atherosclerosis in middle-aged subjects:association with cardiovascular risk factors and insulin resistance.
42 Kekäläinen P et al. Family history of coronary heart disease is a stronger predictor of coronary heart disease morbidity and mortality than family history of non-insulin dependent diabetes mellitus.
43 Koivumaa-Honkanen H-T et al. Correlates of life satisfaction among psychiatric patients.
44 Kotilainen P et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome.
45 Kuusisto J. Risk Factors for Non-Insulin-Dependent Diabetes, Coronary Heart Disease and Stroke in Elderly Subjects.
46 Kuusisto J et al. Hyperglykemia lisää sydän- ja verisuonitauteihin sairastuvuutta aikuistyypin diabeteksessa.
47 Laakso M. Glycaemic control and macrovascular disease in NIDDM.
48 Laakso M. Long-term influence of glycaemic control on cardiovascular risk in NIDDM.
49 Laakso M. Glycemic Control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: the Finnish studies.
50 Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus.
51 Laakso M. Insulin resistance and coronary heart disease.
52 Laakso M, Jantunen E. Bisphosphonate therapy in multiple myeloma.
53 Laakso M et al. Effects of Losartan on insulin sensitivity in hypertensive subjects.
54 Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atheroslecrotic vascular disease in non-insulin-dependent diabetes mellitus.
55 Laaksonen DE et al. Increased resting and excercise-indused oxidative stress in young IDDM men.
56 Laitinen T et al. Baroreflex sensitivity and it's components during the phenylephrine test in healthy young subjects.
57 Lakka TA et al. Conditioning leisure time physical activity and cardiorespiratory fitness in sociodemographic groups of middle-aged men in Eastern Finland.
58 Laks T et al. Acute myocardial infarction in Estonia: first results from the Tallinn AMI Register.
59 Legget ME et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis.
60 Lehto S. Predictors of Atherosclerotic Vascular Disease in Patients with Non-Insulin-Dependent Diabetes Mellitus.
61 Lehto S et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus.
62 Lehto S et al. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes.
63 Lehto S et al. Risk factors predicting lower extremity amputations in patients with NIDDM.
64 Malin M et al. Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.
65 Miettinen H et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-insulin-dependent diabetic subjects.
66 Miettinen H et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.
67 Miettinen H et al. Sydäninfarktiin sairastuneiden lääkehoitokäytäntö Suomessa vuosina 1986-1992. FINMONICA-tutkimuksen tuloksia.
68 Miettinen H et al. Retinopathy predicts coronary heart disease events in NIDDM patients.
69 Miettinen H, Salomaa V. Diabetes and macrovascular disease.
70 Mustonen J et al. Sydänperäisen syyn takia hoitoon hakautumisen ja alkuvaiheen hoidon viiveet Pohjois-Karjalan keskussairaalassa.
71 Mykkanen L et al. Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?
72 Mäntysaari M et al. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.
73 Möttönen T. Nivelreuman ennustetta voidaan parantaa.
74 Möttönen T. Milloin systeeminen kortikosteroidihoito nivelreumassa?
75 Möttönen T et al. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" srategy.
76 Nieminen U, Jantunen E. Trombosytopeniat.
77 Niskanen L. Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword?
78 Niskanen L et al. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects.
79 Niskanen L et al. The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects.
80 Niskanen L, Voutilainen R, eds. XXII Spring Meeting of The Finnish Endocrine Society. Kuopio, Finland 10.-11.5.1996. Program and Abstracts.
81 Niskanen LK et al. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM.
82 O'Brien KD et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.
83 Pedersen TR et al. Safety and tolerability of cholesterol lowering with Simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
84 Pedersen TR et al. Cholesterol lowering and the use of healthcare resources: Results of the Scandianavian Simvastatin Survival Study.
85 Peltola JT et al. Circulating autoantibodies to a 240 KD fetal brain protein.
86 Pikkarainen P. Ruokatorven refluksitauti ja sen hoito.
87 Pikkarainen P. Milloin systeeminen kortisonihoito tulehduksellisissa suolistosairauksissa?
88 Pikkarainen P. Vatsa ja ruuansulatuselimistö.
89 Pulkki K et al. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma.
90 Pyörälä K. CHD prevention in clinical practice.
91 Pyörälä K, Steiner G. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence.
92 Rönnemaa T et al. Smoking is independently associated with high plasma insulin levels in nondiabetic men.
93 Salomaa V et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study.
94 Sarkkinen E et al. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance.
95 Steiner G for the DAIS Project Group. The diabetes atherosclerosis intervention study (DAIS): a study conducted in cooperation with the World Health Organization.
96 Suomen Sisätautilääkärien yhdistyksen, Suomen Kardiologisen seuran, Suomen Verenpaineyhdistyksen, Kunnallislääkärit-yhdistyksen, Suomen Teollisuuslääketieteen yhdistyksen ja Suomen Sydäntautiliiton työryhmä. Sepelvaltimotaudin ehkäisy käytännön lääkärintyössä.
97 Sutas Y et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus casei GG-derived enzymes.
98 Säily M et al. Effect of interferon-alfa on immunoglobulin production by peripheral blood mononuclear cells in multiple myeloma.
99 Takala J et al. Prevention of pressure sores in acute respiratory failure: a randomised controlled trial.
100 Töyry JP et al. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus.
101 Töyry JP et al. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis.
102 Töyry JP et al. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM.
103 Uusitupa M et al. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
104 Uusitupa MIJ et al. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women 1-3.
105 Uusitupa MIJ et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
106 Vanhanen M et al. ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM.
107 Vidgren HM et al. Altered fatty acid composition of serum lipids in patients with non-insulin-dependent diabetes.
108 Viinamäki H et al. Rapidly declining mental well-being during unemployment.
109 Viinamäki H et al. Factors predicting psychosocial recovery in psychiatric patients.
110 Vuoristo M-S et al. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008